Drug Type Small molecule drug |
Synonyms HMPSNE |
Target |
Action inhibitors |
Mechanism MPST inhibitors(mercaptopyruvate sulfurtransferase inhibitors), caspase 1 inhibitors(Caspase-1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H14N2O2S |
InChIKeyKKPLVAUVHOSUPR-UHFFFAOYSA-N |
CAS Registry459420-09-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | United States | 02 Mar 2025 | |
Inflammation | Preclinical | Japan | 02 Mar 2025 |